Active Biotech AB logo — company profile

Active Biotech AB

Founded 1998 Sweden Sweden 21 employees Biotechnology

General Information

Company Name Active Biotech AB
Founded Year 1998
Location Sweden Sweden
Employees 21
Industries Biotechnology
Social

Get notified when Active Biotech AB moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Active Biotech AB

Active Biotech AB, a biotechnology company founded in 1996 and based in Sweden, is focused on developing first-in-class immunomodulatory treatments for specialist oncology and immunology indications with significant commercial potential. The company has repositioned its portfolio to concentrate on advancing projects to the clinical development phase and then further developing the programs internally or pursuing partnerships. Currently, Active Biotech holds three key projects in its portfolio: tasquinimod and laquinimod, small molecule immunomodulators targeted towards hematological malignancies and inflammatory eye disorders, and Naptumomab, a targeted anti-cancer immunotherapy partnered to NeoTX Therapeutics. Tasquinimod is in clinical phase Ib/IIa for the treatment of multiple myeloma, while Laquinimod is in a clinical phase I study with a topical ophthalmic formulation, to be followed by phase II for the treatment of non-infectious uveitis. Naptumomab is in a phase Ib/II clinical program in patients with advanced solid tumors, demonstrating the company's focus on addressing high unmet medical needs. Active Biotech's commitment to developing innovative treatments in the biotechnology industry positions it as a promising player with potential for significant impact and commercial success. For more information, please visit www.activebiotech.com.

Taxonomy: immunomodulatory treatments, oncology, immunology, clinical development, small molecule immunomodulators, hematological malignancies, inflammatory eye disorders, multiple myeloma, non-infectious uveitis, anti-cancer immunotherapy, solid tumors, pharmaceutical research, clinical trials, commercial potential

No funding data available for Active Biotech AB yet.

Get notified when Active Biotech AB raises funding

Active Biotech AB Alternatives & Competitors

Active Biotech AB vs
Cyxone
Cyxone Sweden

Life-changing treatments for disorders of the immune system

11 employees
Biotechnology, Health Care
Active Biotech AB vs
Redx Pharma
Redx Pharma United Kingdom

Biotech company focusing on the discovery and development of novel targeted medicines to treat cance...

Post Ipo Equity
39 employees
Biotechnology, Health Care
Active Biotech AB vs
Bionure
Bionure Spain

Clinical stage biotech developing new drugs for CNS diseases.

Series A
8 employees
Biotechnology, Health Care

FAQ About Active Biotech AB

Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge base and portfolio of compounds to develop first-in-class immunomodulatory treatments for specialist oncology and immunology indications with a high unmet medical need and significant co...
Active Biotech AB was founded in 1998.
Active Biotech AB is headquartered in Sweden.
Active Biotech AB operates in the following industries: Biotechnology.
Active Biotech AB has approximately 21 employees.
Top alternatives and competitors to Active Biotech AB include Cyxone, Redx Pharma, Bionure, Algiax Pharmaceuticals, Neurotrope Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Active Biotech AB and Cyxone are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Active Biotech AB and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy